Nursing homes get looser doctor rules—patient safety unclear

What it does

This bill expands who can supervise and provide care in Medicare and Medicaid-certified skilled nursing facilities by allowing nurse practitioners, physician assistants, and clinical nurse specialists to work independently or in collaboration with physicians, rather than requiring direct physician oversight. The changes apply across multiple care-delivery and certification sections, giving states flexibility to define supervision requirements.

Why we flagged it

The bill's core function is to relax physician-supervision requirements in nursing facilities by expanding the scope of practice for non-physician clinicians. While framed as 'enhancing' care delivery, the mechanism is fundamentally deregulatory—it removes a longstanding safeguard (physician oversight) and delegates authority to state law.

What the text implies

• Shifting supervision from physicians to lower-cost clinicians may reduce facility operating costs, potentially benefiting for-profit nursing home chains (DVA, GH) and their investors, while patient safety outcomes remain uncertain.
• Deferring to 'state law' creates a patchwork of supervision standards across the country, potentially allowing states with weaker regulations to reduce oversight further, creating a race-to-the-bottom dynamic.
• The bill does not establish new training, credentialing, or liability standards for nurse practitioners, physician assistants, and clinical nurse specialists in nursing-facility settings, leaving gaps in accountability.
• Pharmaceutical companies (BMY, PFE, JNJ) may benefit indirectly if reduced physician oversight leads to higher medication utilization rates in facilities, though this is speculative.

Who it affects

Potential benefits: expanded access to care in nursing facilities where physician shortages exist, and lower labor costs that may reduce patient fees. Potential costs: reduced physician oversight could compromise care quality and patient safety, particularly for complex cases; the bill defers to state law, creating inconsistent protections across states.

Who stands to gain

• for-profit nursing home operators (DVA, GH)
• healthcare staffing agencies
• nurse practitioner and physician assistant employers
• pharmaceutical companies (indirect, via increased utilization)

Named in the bill

Medicare, Medicaid, Social Security Act (Sections 1814, 1819, 1842, 1861, 1902, 1919), skilled nursing facilities, nursing facilities, intermediate care facilities, physician assistants, nurse practitioners, clinical nurse specialists, DVA (DaVita HealthCare Partners), GH (Encompass Health), BMY (Bristol Myers Squibb) — and 2 more

Where it stands

1 cosponsor: 1 Democrats.

• Jan 15, 2026 — Introduced · Congress.gov: “Introduced in House”
• Jan 15, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

7 lobbying clients named this bill on 7 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $1,793,067 in lobbying spend. A filing names 47 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 86% of bills with at least one filing.

Jennifer Kiggans, the sponsor, reported $1,313,089 in PAC receipts in the 2026 cycle.

• American Health Care Association — $840,000 on 1 filing
• American Association of Nurse Practitioners — $400,000 on 1 filing
• American Nurses Association — $270,000 on 1 filing
• American Academy of Physician Associates — $160,000 on 1 filing
• American Association of Nurse Practitioners — $70,000 on 1 filing

Lobbying Disclosure Act filings through Jul 22, 2026. A filing shows who paid to lobby on a bill it names, not what changed.